The ISA-95 (IEC 62264) Enterprise-Control System Integration (part 1, part 2, part 3, part 4, part 5) international standard provides a model to help define the boundaries between the enterprise systems and process control systems. As manufacturing operations seek to...
Projects to connect your process operations to your business processes and workflows typically require connections with several specialized software platforms. For manufacturers in the pharmaceutical and biotech industries, these electronic connections span the ISA-95...
One of the conversations happening among pharmaceutical and biotech manufacturers is around the "facility of the future". I caught up with Emerson's Gary Mitchell, a consultant on the Life Sciences industry team. He shared some of the trends prompting this relook at...
I wanted to share my guest post over at the PharmaEvolution.com blog, Justifying New Tech Investment When the Plant Is Running Full Out. It can often be challenging to justify investing in new technology when a plant has spare capacity, as Michalle Adkins mentioned...
Models can help bring understanding to complex processes. In batch manufacturing, one of the benefits from generating models from process history data is the process understanding gained by going through the steps of generating and refining the model. These steps...
Justifications for automation investments can be based on many factors—increasing revenues, reducing costs, increasing working capital efficiency, and maximizing the return on fixed capital. How do you justify automation investments from a production process not...
In an article, From Industrial To Investment Strategies In The Life Science Sector, Life Science Leader magazine has a great recap of some of the issues pharmaceutical and biotech manufacturers face in their manufacturing processes. The article highlights...
I recently saw an interesting discussion about the use of consultants. One question that came up was why they seem to ask the same question in slightly different ways or the same question to different functional groups in an organization. Emerson's Michalle Adkins, a...
An important part of a smooth running plant is optimizing the performance of the control loops. Emerson's Mark Coughran, a senior process control consultant, describes and shares examples of how loop optimization is a part of a control performance program in regulated...
For those in the biotech and pharmaceutical manufacturing industries, Emerson's Chris Amstutz has been sharing a great series of forum posts in the Emerson Exchange 365 community, Life Sciences track. Here are a few examples of some specific SAP to manufacturing...
For pharmaceutical and biotech manufacturers, the process of drug compound experimentation requires robust and reproducible results before the scale up process can begin. Emerson's Chris Amstutz pointed me to a great whitepaper by Broadley James, Automating Industrial...
Over the past several years, I've covered the advancements in batch analytics to improve the efficiency of batch processes and spot troubles early enough to avoid or resolve the trouble. There can be many simultaneous complex activities in batch operations including...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.